Novavax

Forecast & Rating9 analysts currently cover Novavax, with about 55.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $14.11, about 89.2% upside from the current price of $7.46. Price targets range from $7.00 to $25.00 — a wide spread, showing clear disagreement over just how much Novavax can rise. Historically, about 37.9% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Novavax are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 17, 2026; for reference only and not investment advice.